Heron Therapeuti (HRTX) — Capital Reinvestment Ratio

Latest as of September 2024: 0.13x

Heron Therapeuti (HRTX) has a Capital Reinvestment Ratio of 0.13x as of September 2024, meaning it reinvests 0% of its operating cash flow ($3.37 Million) in capital expenditures ($431.00K). Check HRTX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.13x
Capex / Operating Cash Flow

Operating Cash Flow

$3.37 Million
USD

Capital Expenditures

$431.00K
USD

Data as of

Sep 2024
Most recent filing

Heron Therapeuti Capital Reinvestment Ratio (2006–2006)

This chart tracks Heron Therapeuti's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see HRTX cash flow conversion.

Annual Capital Reinvestment Ratio for Heron Therapeuti (2006–2006)

Year-by-year Capital Reinvestment Ratio for Heron Therapeuti from 2006 to 2006. See Heron Therapeuti free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2006 0.02x $9.18 Million $187.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow